Biotechnology Portfolio


The Trust consists of a portfolio of common stocks. The Trust seeks above-average capital appreciation.

Strategy Description

While biotechnology has already had a significant impact on the diagnosis, treatment and prevention of diseases, the Sponsor believes further advances could potentially bring about radically new approaches to health care.

The Trust is concentrated in stocks of health care companies.



Series 45

Asset Class

Investment Strategy/Goal

Investment Type/Style